#Sample Identifier	Patient Identifier	Date added to cBioPortal	Month added to cBioPortal	Week added to cBioPortal	CRDB_SURVEY_COMMENTS	Cancer Type	Sample Type	Sample Class	Metastatic Site	Primary Tumor Site	Cancer Type Detailed	Gene Panel	SO comments	Sample coverage	Tumor Purity	Oncotree Code	MSI Comment	MSI Score	MSI Type	Institute Source	Somatic Status	Archer Panel	Impact TMB Percentile (Across All Tumor Types)	Impact TMB Score	Impact TMB Percentile (Within Tumor Type)	MSK Pathology Slide Available	MSK Slide ID	WHO Grade	MGMT Status
#A unique sample identifier.	Identifier to uniquely specify a patient.	Date added to cBioPortal	Month added to cBioPortal	Week added to cBioPortal	The survey comments at enrollment for 12-245.	Cancer Type	The type of sample (i.e., normal, primary, met, recurrence).	The sample classification (i.e., tumor, cellline, xenograph).	The anatomic location to which the cancer has spread.	Text term to describe the organ sub-division in an individual with cancer.	Cancer Type Detailed	Gene panel.	Sign-out comments	Sample coverage	Tumor Purity	Oncotree Code	MSI Comment	MSI Score	MSI Type	Institute Source	Somatic Status	Archer Panel	Percentile for the TMB within the MSK-IMAPCT cohort	Calculated TMB score	Percentile for the TMB within the Tumor type cohort (at least 10 cases are needed in that tumor type to have a result for this)	Indicates the existence of a MSK Pathology slide. 	MSK Slide ID	WHO Grade	MGMT Status
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	NUMBER	NUMBER	NUMBER	STRING	STRING	STRING	STRING
#0	0	0	0	0	0	1	1	0	0	0	1	1	0	1	1	0	0	1	1	1	1	0	0	1	0	0	0	0	0
SAMPLE_ID	PATIENT_ID	DATE_ADDED	MONTH_ADDED	WEEK_ADDED	CRDB_SURVEY_COMMENTS	CANCER_TYPE	SAMPLE_TYPE	SAMPLE_CLASS	METASTATIC_SITE	PRIMARY_SITE	CANCER_TYPE_DETAILED	GENE_PANEL	SO_COMMENTS	SAMPLE_COVERAGE	TUMOR_PURITY	ONCOTREE_CODE	MSI_COMMENT	MSI_SCORE	MSI_TYPE	INSTITUTE	SOMATIC_STATUS	ARCHER	CVR_TMB_COHORT_PERCENTILE	CVR_TMB_SCORE	CVR_TMB_TT_COHORT_PERCENTILE	PATH_SLIDE_EXISTS	MSK_SLIDE_ID	WHO_GRADE	MGMT_STATUS
P-0000101-T01-IM3	P-0000101	2015/04/07	2015/04	2015, Wk. 15		Mesothelioma	Primary	Tumor	Not Applicable	Pleura	Pleural Mesothelioma, Epithelioid Type	IMPACT341		842	30	PLEMESO	MICROSATELLITE STABLE (MSS). See MSI note below.	0.00	Stable	MSKCC	Matched	NO				NO	NA		
P-0000103-T03-IM6	P-0000103	2017/01/31	2017/01	2017, Wk. 05		Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	Metastasis	Tumor	Liver	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT468		558	50	USC	MICROSATELLITE STABLE (MSS). See MSI note below.	1.46	Stable	MSKCC	Matched	YES	52.4	4.4	29.0	YES	547333		
P-0000103-T02-IM5	P-0000103	2016/03/30	2016/03	2016, Wk. 13		Endometrial Cancer	Metastasis	Tumor	Peritoneum	Uterus	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	IMPACT410		1147	30	USC	Not Available	0.15	Stable	MSKCC	Matched	NO	25.2	2	9.2	YES	409752		
P-0000106-T02-IM3	P-0000106	2015/04/07	2015/04	2015, Wk. 15		Breast Cancer	Primary	Tumor	Not Applicable	Breast	Breast Invasive Ductal Carcinoma	IMPACT341		344	N/A	IDC	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	4.10	Indeterminate	MSKCC	Matched	NO	17.1	1.1	13.5	NO	NA		
P-0000106-T03-IM3	P-0000106	2015/04/07	2015/04	2015, Wk. 15		Non-Small Cell Lung Cancer	Metastasis	Tumor	Neck	Lung	Lung Adenocarcinoma	IMPACT341		428	N/A	LUAD	MICROSATELLITE STABLE (MSS). See MSI note below.	0.47	Stable	MSKCC	Matched	NO	96.7	33.5	98.3	NO	NA		
